nznsbe | Knowledge4COVID-19

Property	Value
?:abstract	The article Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/28nznsbe_hasAnnotation_C1960398> <https://research.tib.eu/covid-19/entity/28nznsbe_hasAnnotation_C4553887>
?:creator	<https://research.tib.eu/covid-19/entity/L%C3%BCftner%2C_Diana%3B_Lyman%2C_Gary_H%3B_Gon%C3%A7alves%2C_Jo%C3%A3o%3B_Pivot%2C_Xavier%3B_Seo%2C_Minji>
?:license	unk
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:source	WHO
?:title	Correction to: Biologic Drug Quality Assurance to Optimize HER2+ Breast Cancer Treatment: Insights from Development of the Trastuzumab Biosimilar SB3
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:who_covidence_id	#33079308
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/28nznsbe>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/28nznsbe>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all